Factors Associated with HPV Vaccination Uptake and HPV-Associated Cancers: A County-Level Analysis in the State of Alabama

被引:15
|
作者
Vickers, Macy [1 ]
Green, Chelsea L. [1 ]
Lee, Hee Yun [2 ]
Pierce, Jennifer Y. [1 ]
Daniel, Casey L. [1 ]
机构
[1] Univ S Alabama, Mitchell Canc Inst, Div Canc Control & Prevent, 1660 Springhill Ave, Mobile, AL 36604 USA
[2] Univ Alabama, Sch Social Work, Tuscaloosa, AL USA
关键词
HPV; Human papillomavirus; Vaccination; Cancer; Prevention; HUMAN-PAPILLOMAVIRUS; ADOLESCENTS; BARRIERS; GIRLS;
D O I
10.1007/s10900-019-00690-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Despite availability of a safe, effective vaccination, uptake and completion rates of human papillomavirus (HPV) vaccination remain low in the United States. This is particularly true in the southeast, which also sees some of the highest rates of HPV-associated (HPVa) cancers. We aimed to identify areas in Alabama in need of intervention with respect to HPVa cancers and HPV vaccination, and factors potentially associated with these rates by performing county-level secondary data analysis using state and national data sources. Alabama ranks 15th nationally in HPVa cancer rates, with 66.7% and 80.8% of counties having higher HPVa cancer rates than the national incidences of males and females, respectively. Regarding HPV vaccination, 95.5% and 98.5% of Alabama's counties have uptake rates less than the national averages for males and females, respectively. The seven counties with the highest HPV vaccination uptake ranged in rates from 60.2 to 73.6%. Counties with the highest HPV vaccination rates for adolescents were majority African American with low adult educational attainment rates and high rates of poverty and publicly-insured children/adolescents. These counties were also located in Alabama's Black Belt region, traditionally known for low socioeconomics, reduced access to social services, and negative health outcomes. Some counties with the highest rates of HPVa cancers also had among the highest rates of HPV vaccination, indicating a potential association between perceived susceptibility and desire to get HPV vaccine in these communities, warranting further investigation. Future work is needed to translate these findings into actionable intervention practices to increase HPV vaccination.
引用
收藏
页码:1214 / 1223
页数:10
相关论文
共 50 条
  • [21] HPV-Associated Head and Neck Cancers: An Update
    Helliwell, T. R.
    JOURNAL OF PATHOLOGY, 2017, 243 : S8 - S8
  • [22] HPV-Associated Head and Neck Cancers Preface
    Pai, Sara I.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2012, 45 (04) : XI - XII
  • [23] Molecular pathogenesis of HPV-associated genital cancers
    不详
    ACTA CYTOLOGICA, 2005, 49 (06) : 681 - 681
  • [24] p16 in HPV-associated cancers
    Munger, Karl
    Gwin, Tyshia K.
    McLaughlin-Drubin, Margaret
    ONCOTARGET, 2013, 4 (11) : 1864 - 1865
  • [25] HPV-p53-miR-34a axis in HPV-associated cancers
    Chen, Jiezhong
    Zhao, Kong-Nan
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (21)
  • [26] The mechanisms by which HPV vaccines induce protection against HPV-associated cancers
    Lowy, D. R.
    Day, P. M.
    Thompson, C. D.
    Pang, Y. S.
    Kines, R. C.
    Schiller, J. T.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 : 59 - 59
  • [27] The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers
    Qi, Shi-Yu
    Yang, Miao-Miao
    Li, Chong-Yang
    Yu, Kun
    Deng, Shou-Long
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] HPV9: Combating HPV-associated cancers by strengthening serotype defenses
    Dougherty, Stephanie A.
    Hayney, Mary S.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2015, 55 (06) : 670 - 672
  • [29] SOCIAL AND BEHAVIORAL FACTORS ASSOCIATED WITH HPV VACCINATION UPTAKE IN ADOLESCENTS
    Gebremeskel, Roman H.
    Haney, Chassidy J.
    Coyne-Beasley, Tamera
    JOURNAL OF ADOLESCENT HEALTH, 2014, 54 (02) : S31 - S31
  • [30] Current and Future Vaccines to Prevent HPV-associated Cancers
    Lowy, D. R.
    Day, P. M.
    Kines, R. C.
    Thompson, C. D.
    Schiller, J. T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S7 - S7